Centene Corporation (BVMF:C1NC34)
Brazil · Delayed Price · Currency is BRL 197.62
-22.50 (-10.22%)
At close: Feb 6, 2026
Centene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 171,556 | 142,303 | 135,636 | 127,131 | 112,319 |
Total Interest & Dividend Income | 1,570 | 1,640 | 1,298 | 520 | 819 |
Gain (Loss) on Sale of Investments | - | - | - | - | -229 |
Other Revenue | 3,025 | 3,202 | 4,459 | 8,348 | 5,664 |
| 176,151 | 147,145 | 141,393 | 135,999 | 118,573 | |
Revenue Growth (YoY) | 19.71% | 4.07% | 3.97% | 14.70% | 13.71% |
Policy Benefits | 157,702 | 125,707 | 118,894 | 111,529 | 98,602 |
Amortization of Goodwill & Intangibles | 685 | 692 | 718 | 817 | 770 |
Depreciation & Amortization | 590 | 549 | 575 | 614 | 565 |
Selling, General & Administrative | 12,878 | 12,305 | 12,407 | 11,366 | 9,376 |
Other Operating Expenses | 3,012 | 2,969 | 3,886 | 7,294 | 5,182 |
Total Operating Expenses | 174,867 | 142,222 | 136,480 | 131,620 | 114,495 |
Operating Income | 1,284 | 4,923 | 4,913 | 4,379 | 4,078 |
Interest Expense | -678 | -702 | -725 | -665 | -665 |
EBT Excluding Unusual Items | 606 | 4,221 | 4,188 | 3,714 | 3,413 |
Merger & Restructuring Charges | -26 | -95 | -253 | -1,844 | -211 |
Impairment of Goodwill | -6,723 | - | - | - | - |
Gain (Loss) on Sale of Assets | 2 | 61 | -352 | 301 | - |
Asset Writedown | -588 | -13 | - | -233 | - |
Legal Settlements | - | - | - | -6 | -1,264 |
Other Unusual Items | 1 | 83 | 15 | 30 | -125 |
Pretax Income | -6,728 | 4,257 | 3,598 | 1,962 | 1,813 |
Income Tax Expense | -51 | 963 | 899 | 760 | 477 |
Earnings From Continuing Ops. | -6,677 | 3,294 | 2,699 | 1,202 | 1,336 |
Net Income to Company | -6,677 | 3,294 | 2,699 | 1,202 | 1,336 |
Minority Interest in Earnings | 3 | 11 | 3 | - | 11 |
Net Income | -6,674 | 3,305 | 2,702 | 1,202 | 1,347 |
Net Income to Common | -6,674 | 3,305 | 2,702 | 1,202 | 1,347 |
Net Income Growth | - | 22.32% | 124.79% | -10.76% | -25.50% |
Shares Outstanding (Basic) | 493 | 522 | 543 | 575 | 583 |
Shares Outstanding (Diluted) | 493 | 524 | 546 | 582 | 591 |
Shares Change (YoY) | -5.85% | -4.02% | -6.24% | -1.44% | 1.97% |
EPS (Basic) | -13.53 | 6.33 | 4.97 | 2.09 | 2.31 |
EPS (Diluted) | -13.53 | 6.31 | 4.95 | 2.07 | 2.28 |
EPS Growth | - | 27.47% | 139.13% | -9.21% | -26.92% |
Free Cash Flow | 4,321 | -490 | 7,254 | 5,257 | 3,295 |
Free Cash Flow Per Share | 8.76 | -0.94 | 13.29 | 9.03 | 5.58 |
Operating Margin | 0.73% | 3.35% | 3.48% | 3.22% | 3.44% |
Profit Margin | -3.79% | 2.25% | 1.91% | 0.88% | 1.14% |
Free Cash Flow Margin | 2.45% | -0.33% | 5.13% | 3.86% | 2.78% |
EBITDA | 2,559 | 6,164 | 6,206 | 5,809 | 5,413 |
EBITDA Margin | 1.45% | 4.19% | 4.39% | 4.27% | 4.57% |
D&A For EBITDA | 1,275 | 1,241 | 1,293 | 1,430 | 1,335 |
EBIT | 1,284 | 4,923 | 4,913 | 4,379 | 4,078 |
EBIT Margin | 0.73% | 3.35% | 3.48% | 3.22% | 3.44% |
Effective Tax Rate | - | 22.62% | 24.99% | 38.74% | 26.31% |
Revenue as Reported | 194,777 | 163,071 | 153,999 | 144,547 | 125,982 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.